Project Grant HT94252410900
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$2.2M
Federal Agency
Defense Health Agency
Awardee
Knoubis Bio Inc. (REVESH5416V4)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92122, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,000,000.00 in funding to Tekhona Inc., a for-profit S corporation, to develop intra-articular immunoregulatory microparticles for inducing systemic remission in rheumatoid arthritis. The 2-year research project, with an award date of September 15, 2023 and an ultimate completion date of September 14, 2025, aims to transform healthcare for Service...
This $1,543,430 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to target thromboinflammation in rheumatoid arthritis. The award was made to Baylor College of Medicine, a leading academic medical center in Houston, Texas, on May 15, 2024, with a period of performance through May 14, 2028. The grant enables Baylor to conduct innovative biomedical research focused on improving health outcomes...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $5,099,737.00 in funding to 149 Bio LLC, a for-profit organization based in Miami, Florida. The grant supports the development of a "MYELOID-TARGETED NOVEL THERAPEUTIC FOR GLOMERULAR DISEASES", with a project period from July 1, 2025 to June 30, 2029. The funded research aims to transform healthcare for military service members and the...
The Defense Health Agency awarded a $2,401,711.00 Project Grant on August 15, 2023 to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The grant supports a 4-year research project focused on "JOINT SHAPE CHANGE AS A TARGET FOR THE UNDERSTANDING, DIAGNOSIS, PREVENTION, AND TREATMENT OF OSTEOARTHRITIS." As a sub-award under this grant, Sutter Bay Hospitals' California Pacific Medical Center...
This $999,392 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research initiatives at the University of Houston System. The funding will be used to conduct research on PRMT5 in lupus nephritis, with a performance period from September 1, 2025 through August 31, 2029. The Military Medical Research and Development program focuses on transforming healthcare for military service...
This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
This $2,377,839 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support evidence-based research to predict cardiovascular risk in immune-mediated inflammatory diseases. The grant was awarded on June 1, 2025 to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center with extensive biomedical research capabilities. Through this 4-year grant, UCSF researchers will...
This $300,000 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Duke University. The grant supports research to investigate the "complement-activating properties of anti-SM/RNP antibodies in SLE" over a 2-year period from September 1, 2024 to August 31, 2026. The award will enable Duke University's medical researchers to conduct advanced biomedical studies on the role of certain antibodies in systemic...
This federal Project Grant award, valued at $300,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to The Administrators of Tulane Educational Fund, doing business as Tulane University. The award will fund research to determine risk factors for lupus nephritis through the intersection of glycobiology and immunometabolism. The research will be conducted at Tulane University in New Orleans, Louisiana over a 2-year period...
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...